Mazo, C.; Barron, S.; Mooney, C.; Gallagher, W.M.
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients. Cancers 2020, 12, 1133.
https://doi.org/10.3390/cancers12051133
AMA Style
Mazo C, Barron S, Mooney C, Gallagher WM.
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients. Cancers. 2020; 12(5):1133.
https://doi.org/10.3390/cancers12051133
Chicago/Turabian Style
Mazo, Claudia, Stephen Barron, Catherine Mooney, and William M. Gallagher.
2020. "Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients" Cancers 12, no. 5: 1133.
https://doi.org/10.3390/cancers12051133
APA Style
Mazo, C., Barron, S., Mooney, C., & Gallagher, W. M.
(2020). Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients. Cancers, 12(5), 1133.
https://doi.org/10.3390/cancers12051133